Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Suzhou Erye Pharmaceutical is a prominent Chinese pharmaceutical company specializing in the research, development, and large-scale manufacturing of anti-infective medications. Founded in 1946, the company has established itself as a major producer of penicillin and cephalosporin APIs and finished dosage forms. It operates multiple GMP-certified production facilities and is a key subsidiary of Shanghai Fosun Pharmaceutical. The company's product portfolio includes a wide range of antibiotics, cardiovascular drugs, and gastrointestinal medications, serving both domestic and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Suzhou Erye Economy.